IRVINE, Calif., January 07, 2026--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...

While headlines celebrated the patent infringement verdict, exclusive Benzinga Edge’s Stock Rankings data reveals that Masimo's quality score has tumbled to 10.43, placing it in the bottom tier of ...

Shares of Masimo Corporation have reached a 52-week low, trading at 131.47 USD, down from its 52-week high of 194.88 USD. This milestone comes amid a challenging year for the company, with its stock ...

Despite a whopping $634 million patent infringement victory against Apple, Masimo is showing signs of weakness in its underlying fundamentals. According to Benzinga Edge's Stock Rankings data, ...